Resq Pharma, Inc
ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an antidote for various non-opiate drug overdoses and poisonings including all local anesthetics (Lidocaine, Bupivacaine, etc.), benzodiazepines and psychotherapeutics (all antidepres). The FDA recently approved Orphan Drug Designation for LRT's initial sought after indication, local anesthetic systemic toxicity (LAST). ResQ Pharma plans to file applications for market approval for both the USA and EU by the 1st quarter of 2019. In 2015, within the U.S. alone, over people died from drug overdoses and poisonings, potentially treatable with LRT.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Resq Pharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Resq Pharma, Inc
1 distinct titles indexed · top 1 shown.
- 1president
Sign up to unlock all 1 contacts at Resq Pharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Resq Pharma, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.